Question 1

What are the top holdings in PSIL?

Accepted Answer

AdvisorShares Psychedelics ETF (PSIL) holds 30 securities. View the complete list of top holdings sorted by portfolio weight, showing each security's ticker symbol, company name, asset type, and allocation percentage.

Question 2

How concentrated is PSIL's portfolio?

Accepted Answer

Portfolio concentration is measured by the weight of top holdings. A concentrated portfolio has fewer large positions with higher individual weights, while a diversified portfolio distributes holdings more evenly. Review PSIL's holdings table to analyze concentration risk.

Question 3

What is PSIL's sector allocation?

Accepted Answer

The Sector Allocation chart shows how PSIL distributes investments across different industries like Technology, Healthcare, Financials, and more. This sector exposure helps understand the fund's industry diversification strategy.

Question 4

What countries does PSIL invest in?

Accepted Answer

PSIL's geographic exposure is shown in the Countries tab under Portfolio Allocations. This reveals the fund's international diversification and exposure to different regions and global markets.

Question 5

How diversified is PSIL ETF?

Accepted Answer

PSIL's diversification can be assessed by reviewing its 30 holdings, sector allocation, and geographic exposure. A well-diversified ETF spreads investments across multiple securities, sectors, and regions to reduce concentration risk.

Question 6

What are PSIL's largest positions by weight?

Accepted Answer

PSIL's largest positions are listed in the holdings table, sorted by portfolio weight percentage. The top holdings represent the securities with the highest allocation in the fund's portfolio composition.

#	Symbol	Name	Type	Weight
1	ATAI	ATAI Life Sciences BV	Stock	10.67%
2	D DFTX	Definium Therapeutics, Inc.	Stock	9.57%
3	RLMD	Relmada Therapeutics, Inc	Stock	9.13%
4	MNMD	Mind Medicine (MindMed) Inc	Stock	8.20%
5	ALKS	Alkermes plc	Stock	8.03%
6	CMPS	COMPASS Pathways plc	Stock	7.90%
7	SUPN	Supernus Pharmaceuticals, Inc	Stock	7.15%
8	NBIX	Neurocrine Biosciences, Inc.	Stock	6.02%
9	GHRS	GH Research PLC	Stock	5.86%
10	ANRO	ANRO	Stock	5.41%
11	NRXP	NRX Pharmaceuticals Inc	Stock	5.23%
12	C CSE:DRUG	Bright Minds Biosciences Inc.	Stock	4.67%
13	ABBV	AbbVie Inc.	Stock	4.46%
14	N NEO:HELP	Cybin Inc.	Stock	4.39%
15	JNJ	Johnson & Johnson	Stock	4.34%
16	NEUP	Neuphoria Therapeutics Inc.	Stock	3.21%
17	STIM	Neuronetics, Inc.	Stock	2.63%
18	SILO	Silo Pharma Inc	Stock	1.40%
19	KTTA	Pasithea Therapeutics Corp.	Stock	1.39%
20	C CSE:QNTM	Quantum BioPharma Ltd.	Stock	1.35%
21	T TSX:NUMI	Numinus Wellness Inc.	Stock	1.05%
22	IXHL	Incannex Healthcare Inc.	Stock	0.99%
23	VTGN	Vistagen Therapeutics, Inc.	Stock	0.76%
24	ENVB	Enveric Biosciences, Inc.	Stock	0.25%
25	CMND	Clearmind Medicine Inc. Common Shares	Stock	0.19%

PSIL ETF Holdings: AdvisorShares Psychedelics ETF

Portfolio Allocations

Top 25 Holdings by Portfolio Weight